VARIANCE AND EVOLUTION OF HUMAN SKIN PIGMENTATION
=================================================

Understanding the fascinating history of pigmentation biology requires the integration of evolution, genetics, and developmental biology. In vertebrates, pigmentation varies widely from black and white stripes of zebra to muted browns in sparrows to bright colors of tropical fish. Thus, the pigmentation system has served as a model for a wide variety of studies providing some connections between genotype and phenotype for evolutionary important pigmentation traits. Skin color primarily depends on the functions of melanocytes, the cells specialized in the synthesis and distribution of the melanin pigment. In the epidermis, each melanocyte is connected through its dendrites with approximately 30\~40 keratinocytes, establishing the so-called epidermal melanin unit[@B1], and to fibroblasts in the underlying dermis. Within melanocytes, melanin synthesis occurs in specialized membrane-bound organelles termed melanosomes, characterized by four stages of maturation, along with they gradually become pigmented. Specialized melanogenic enzymes within melanosomes, tyrosinase and tyrosinase-related ones, direct the production of two melanin types: black-brown eumelanins, the major pigment found in dark skin and hair, and yellow/red pheomelanin, mainly observed in red hair and I/II skin phototypes[@B2]. The number of melanocytes is relatively comparable among different ethnicities[@B3][@B4] and variations in skin color are mainly dependent on the type (the relative quantity of pheo and eumelanins) and the amount of melanin produced within melanosomes. Size, quantity, distribution and degradation of these structures in the surrounding keratinocytes are also determinants in ethnic color differences. In light skin, melanosomes are smaller and mainly at an early stage of maturation (stages I and II). They are transferred to keratinocytes as clusters and are degraded at the level of the spinous layer. In dark skin, these structures are larger, at stage IV and are singly transferred to the surrounding cells. Their degradation appears also slower than that in the light skin, being some melanins yet observed in the stratum corneum[@B5][@B6]. Moreover, the ratio between pheo and eumelanins appears higher in dark versus light skins ([Fig. 1](#F1){ref-type="fig"})[@B7]. Besides the underlying biological bases, variation in human skin and hair color is the most notable aspect of human variability and explaining which mechanisms support differences in skin color across the world\'s populations has been one of the central questions of human biology. The association of dark skin pigmentation with intense sunshine and heat was postulated by Aristotle into a \"climatic theory\" which related human features to the environment. Later, naturalists such as John Mitchell and Samuel Stanhope Smith related differences in skin pigmentation of world\'s people (from light toward the poles to dark near the equator) to the latitudinal gradient sunshine heat[@B8][@B9]. Today we can say more precisely that variations in skin color are adaptive and related to ultraviolet (UV) radiation levels, correlate with latitude and represent a solution to the physiological requirements of photoprotection and vitamin D synthesis[@B10].

It is likely that the integument of early members of the hominid family was white or lightly pigmented and covered with dark hair. The evolution of a naked, darkly pigmented integument occurred to protect sweat glands from UV-induced injury thus ensuring the quality of somatic thermoregulation. The migration of hominids outside of the tropics placed pressure on skin pigmentation levels because of lower and more seasonal levels of UV. Simultaneously, many degrees of depigmentation evolved to allow UV-B-induced synthesis of vitamin D. Therefore, the range of pigmentation observed in modern humans evolved to favor photoprotection near the equator and to promote cutaneous UV-R-induced vitamin D synthesis closer to the poles.

Several studies in population genetics have allowed to explain the evolution of human pigmentation system. However, the genetics of pigmentation is complex: many genes, that have been identified for decades by using mouse coat color mutations (and more recently zebrafish), are responsible for the range of pigmentation phenotypes contributing to human skin pigment diversity seen both between and within human populations[@B11]. Moreover, variants of some of these genes or single-nucleotide polymorphisms (SNPs) close to them have been found to contribute to normal variation in pigmentary phenotype. Over the past 10 years, the development of high-throughput sequencing technology has allowed to identify associations between pigmentary characteristics and multiple loci across whole genomes. Such genome-wide scans have both confirmed a role for genes previously identified as candidates in human pigmentation and highlighted new loci, thus determining more than one hundred genes that regulate human pigmentary system either directly or indirectly. The expression of such genes is not necessarily confined to melanocytes[@B12][@B13].

Melanocortin 1 receptor (Mc1R), a G protein-coupled receptor that regulates the quantity and quality of melanins produced, was the first gene identified in humans that is involved in regulating mammalian skin and hair color[@B14]. It works by controlling the type of melanin being produced, and its activation causes the switch from phaeomelanin to eumelanin. Mc1R is preferentially expressed in melanocytes but not exclusively limited to them since low levels of Mc1R are also detected in keratinocytes, fibroblasts, and immune cells[@B15]. Several studies showed that Mc1R is highly polymorphic in Northern European populations, whereas is almost without any functionally significant variation in African populations demonstrating the action of selection to maintain dark pigmentation in high-UV-R environments[@B16][@B17].

PHYSIOLOGICAL ASPECTS IN THE CONTROL OF SKIN PIGMENTATION AND DEFENCES: DERMAL-EPIDERMAL CROSS-TALK
===================================================================================================

The development and evolution of such a complex pigmentary system required a fine and integrated regulation of signalling pathways and cellular interactions. Several autocrine/paracrine secreted factors and cell adhesion mechanisms involving both epidermal and dermal constituents, regulate melanocyte homeostasis, determining the constitutive skin pigmentation and, whenever deregulated, the occurrence of pigmentary disorders. Some of these messengers are produced by both the epidermal and dermal cells, whereas others are distinctly synthesized by only one type of cell. UV exposure is the main environmental factor influencing skin pigmentation. Following UV irradiation, pigment redistribution in keratinocytes and skin is stimulated, melanogenesis is increased and the synthesis and secretion of many pro-pigmenting factors are up-regulated. All these factors act by binding to their specific receptors followed by activation of intracellular signalling pathways linked to melanocyte functionality. Among such growth factor/receptor signalling cascades, one of the main pathway is constituted by the pro-opiomelanocortin (POMC) derived peptides (melanocyte-stimulating hormone \[MSH\] and adrenocorticotropic hormone) from keratinocytes and their receptor Mc1R. Following UV exposure the transcription of POMC is stimulated by the induction of the tumor suppressor protein p53 in keratinocytes, thus promoting melanin synthesis in melanocytes via paracrine interactions[@B18]. As previously mentioned, Mc1R mutations, which are more frequently observed in light than in dark skin phototypes, may deregulate the cellular responses to α-MSH, resulting in decreased eumelanin production in both constitutive and UV-mediated pigmentation.

Along with α-MSH, melanocyte growth, differentiation, survival and activity are regulated by other keratinocyte-derived growth factors and cytokines including endothelin (ET)-1, basic fibroblast growth factor (bFGF), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), hepatocyte growth factor (HGF). As well as α-MSH, most of these messengers are up-regulated in response to UV: ET-1 binds to its specific receptor endothelin B receptor on melanocytes but it also enhances the expression of Mc1R[@B19]. Its effect results in the increase of both melanocyte proliferation and melanogenesis[@B19][@B20] and, as for POMC, ET-1 synthesis is induced by p53[@B21]. Upon specific stimuli, e.g. during inflammatory processes, several other mediators, including prostaglandins E2 and F2alpha, thromboxane B2, leukotriene (LT) C4 and LTD4 are released by the surrounding microenvironment and activate melanocytes increasing their dendricity and melanin production[@B22]. Adding complexity to the interplay between keratinocytes and melanocytes, a contribution of the eumelanin intermediate 5,6-dihydroxyindole-2-carboxylic acid, which goes beyond the supplying of pigments, has been shown: the diffusion of this chemical messenger from the producing melanocytes into keratinocytes may provide protection against environmental stimuli such as UV, through the increase of the antioxidant defence systems and differentiation in keratinocytes, thus contributing to the overall epidermis protection[@B23].

Some studies highlight the role of beta defensins, small and hydrophobic members of highly conserved gene families exhibiting antimicrobial activity against a variety of gram-negative and gram-positive bacteria, yeast and viruses, in mediating also human pigmentation. More precisely, some results expand the functional role of beta defensins revealing the cross-talk between beta defensins and the melanocortin system. In fact, at least two human beta defensins, human β-defensin (hBD) 1 and hBD3 may modulate melanocortin receptor signaling *in vivo*, acting not only on Mc1R but also on Mc5R[@B24]. Abdel Malek\'s group defined the role of hBD3 on human pigmentation testing its effects on cultured human melanocytes. HBD3 inhibited α-MSH-induced, but not the forskolin-induced increase in cyclic adenosine monophosphate (cAMP) levels, thus suggesting that hBD3 acted by blocking the Mc1R[@B25]. Moreover, dysregulated expression of hBD3 in the skin may also impair DNA repair responses in UV-induced melanocytes and, consequently, improve melanoma risk[@B26].

Parallel to the paracrine influences via keratinocytes, melanocyte functionality and skin pigmentation are regulated by the active role of both extracellular matrix (ECM) proteins and fibroblasts of the dermal compartment. *In vitro* studies demonstrated the mitogenic and melanogenic influences of ECM proteins such as fibronectin, collagen I and IV on normal human melanocytes and their effect in inhibiting cell vacuolization and death when melanocytes were growing in mitogen-deficient medium[@B27]. In addition, laminins and collagen IV are involved in the adhesion of melanocytes to the basement membrane via integrin interactions[@B28]. Dermal fibroblasts release many soluble factors able to modulate melanocyte activity: some of these factors are produced also by keratinocytes, such as SCF and HGF, others are specifically synthesized by fibroblasts. Most of these messengers favour melanin synthesis and melanocyte proliferation. Among them, neuregulin-1 is up-regulated in fibroblasts obtained from type VI skin respect to those from types I and III and it represents a melanogenic factor in the regulation of the constitutive pigmentation level of darker skin[@B29]. It has been demonstrated that fibroblasts from palmoplantar skin produce higher levels of the Wnt pathway antagonist dickkopf 1 (DKK1) respect to fibroblasts of the trunk. Differently from the growth factors described above, DKK1 exerts an inhibitory effect on melanocyte proliferation and pigment production. Moreover, this soluble factor acts also on keratinocytes, reducing the expression level of the proteinase-activated receptor-2, which is involved in melanosome transfer, thus decreasing also this latter process. These combined effects of DKK1 on both melanocytes and keratinocytes determine the physiological hypopigmentation observed in the epidermis of palms and soles[@B30]. The fibroblast growth factor family member keratinocyte growth factor/fibroblast growth factor 7 (KGF/FGF7) induces melanosome transfer, promoting the phagotytic process via activation and signalling of its specific receptor, keratinocyte growth factor receptor, directly in keratinocytes[@B31][@B32]. Moreover, this growth factor stimulates the production and secretion of the promelanogenic mediator SCF in primary keratinocytes, creating an indirect paracrine network connecting keratinocytes and fibroblasts in the control of melanocyte functions[@B33]. The important role of KGF in promoting skin pigmentation is further demonstrated by additional studies showing the ability of KGF alone and in association with IL1alpha to increase melanin production and deposition in pigmented epidermal equivalents and in human skin explants[@B34]. Besides these autocrine and paracrine interactions, melanocyte functions are also influenced by hormonal factors distally produced, as assessed by the variation of pigmentation observed in the course of endocrine changes e.g.: (i) hyperpigmentation detected during pregnancy as a result of increased estrogen levels; (ii) hyperpigmentation of genital areas due to the action of reproductive hormones[@B35][@B36].

One basic function of the skin is the prevention of water loss from the body. This may represent the first physiological demand for protection, but it is equally true that the skin provides a protective barrier against invading microbial pathogens, while also serving as a habitat for a plethora of commensal bacteria. The stratum corneum provides the first line of defense against pathogenic and environmental assaults and, in fact, the barrier functions of the stratum corneum are interrelated, co-regulated and interdependent. The cohesive structure of the stratum corneum, coupled with its low water content and its acidic pH, allows the growth of the normal flora, while providing a formidable layer of the innate immune system that counteracts the invasion of pathogens[@B37].

The recent skin microbiome analysis of monozygotic and dizygotic Korean twins has allowed to identify and discriminate genetic and environmental effects on the microbiome. In particular, the paper reported a strong association between the composition of skin microbiota and human genetic factors related to skin barrier function[@B38].

The stratum corneum is a multilayered tissue composed of flattened and anucleate corneocytes, surrounded by many lamellae sheets, enriched in ceramides, cholesterol, and free fatty acids. The positioning of these highly hydrophobic lipids within the extracellular domains of the stratum corneum inhibits the outside movement of water[@B39]. However, the lamellar bodies secrete not only lipids but also proteolytic enzymes and antimicrobial peptides (AMPs) including corneodesmosin, hBD-2 and the cathelicidin product, LL-37 by which, after recognizing microbes via Toll-like receptors or NOD-like receptors, the stratum corneum initiates the defense response. Induction of AMPs can be further increased by cytokines released upon infection and inflammation such as interleukin (IL)-1, IL-17 and IL-22[@B40][@B41]. In addition, UV radiation has been identified as a potent inducer of AMPs expression in keratinocytes, thus explaining the absence of infection despite the inhibition of adaptive immunity upon UV radiation[@B42]. The hypothesis that epidermal pigmentation developed in response to UV-B induced stress to the barrier suggests that enhanced function of pigmented skin can be due to the lower pH of the outer epidermis, probably related to the permanence of melanosomes into the outer epidermis and to the conservation of genes associated with eumelanin synthesis and melanosome acidification in pigmented populations. Accordingly, natural selection would have favored mutations that increase and protect permeability barrier function and, in fact, pigmented skin displays superior barrier function[@B43]. On the other hand, the thicknesses of the stratum corneum is higher in not pigmented skin of patients affected by vitiligo, thus giving to the barrier a photoprotective role compensating for absent pigmentation[@B44]. Moreover, very recently, a dysbiosis in the diversity of microbial community structure in vitiligo lesional skin has been reported[@B45].

A further corroboration that skin pigmentation is intricately regulated may be also supported by the link, recently demonstrated, between α-MSH and the peroxisome proliferator-activated receptor (PPAR)-γ in melanocytes[@B46]. Several lines of evidence indicate that cAMP is the main intracellular messenger responsible for the melanogenic actions of α-MSH[@B47]. Moreover, Mc1R signaling recruits c-KIT to activate ERK pathway independently on cAMP in normal human melanocytes and melanoma cells[@B48]. α-MSH-induced melanogenesis may also correlate with the canonical Wnt/β-catenin pathway activity[@B49]. More recently it has been demonstrated that α-MSH activates PPAR-γ and such activation depends on the induction of the phosphatidylinositol (PI(4,5)P~2~/PLC~β~) signalling pathway. Therefore, the receptor Mc1R drives melanogenesis and proliferation through lipid mediators. In fact, α-MSH treatment failed to reduce cell proliferation rates after PPAR-γ inhibition. In agreement with these data, Kang and co-workers[@B50] investigated in a previous study the expression and function of peroxisome PPARs, which belong to the superfamily of nuclear receptors that heterodimerize with the retinoic X receptor and initially known for their important role in fat metabolism and adipocyte differentiation, on melanocyte proliferation, differentiation and melanogenesis. Moreover, PPAR-γ induces differentiation and increases cell antioxidant defense in response to natural or pharmacological agonists both in melanocytes and melanoma cells[@B51].

DEREGULATION OF THE EPIDERMAL-DERMAL INTERPLAY IN PIGMENTARY DISORDERS: PATHOLOGICAL ASPECTS
============================================================================================

Increased production of one or more of pro-melanogenic factors often associated to an altered expression of their receptors have been detected in several hyperpigmentary disorders. Solar/senile lentigines (SLs) are hyperpigmented lesions mainly localized on photodamaged body sites, whose onset is commonly observed along with aging. The underlying mechanisms responsible for the occurence and maintainance of these spots are not yet completely defined. Molecules related to inflammatory and fatty acid metabolism are induced in SL, probably linked to chronical UV exposure. Deregulation in the expression of several pro-melanogenic factors has been demonstrated, involving both keratinocyte- and fibroblast-derived network. In lesional epidermis, ET-1 and its receptor ET-B, SCF and its receptor c-Kit signalling cascades are up-modulated, as well as the expression of α-MSH and Mc1R[@B52]. p53 has been shown to play an important role in the onset of these spots through its ability to induce the pro-pigmenting cytokines ET-1, SCF and POMC. In SL lesions, the expression of KGF and its receptor appears to be increased at early-mid stages, suggesting the involvement of this growth factor in the onset of the pigmented spots. Moreover, the treatment with KGF and KGF associated with IL-1alpha, induces hyperpigmented lesions *in vivo*[@B34][@B53]. In SL the induction of pro-melanogenic growth factors signalling cascades has been highlighted also in the dermis, with high expression of KGF, SCF and HGF in lesional fibroblasts. The crucial contribution of the dermis and, specifically, of photoaged fibroblasts in the formation of SL hyperpigmentation are now increasingly strengthened by a number of *in vitro* models reported in the literature: (i) a higher expression of KGF, SCF and HGF using a model of stress-induced premature senescence in fibroblasts has been reported[@B33]; (ii) Salducci et al.[@B54] showed the ability of conditioned medium produced by UV-exposed aged fibroblasts to induce the main SL features in pigmented reconstructed epidermis; (iii) Duval et al.[@B55] demonstrated an increased epidermal pigmentation in a reconstructed skin model containing natural photo-aged fibroblasts. Very recently, an increased expression of KGF in SL has been reported also in the epidermal compartment, supporting the hypothesis that the transfer and accumulation of this fibroblast-derived growth factor into the epidermis may lead to the persistence of hyperpigmentation[@B56]. In the progression of this altered dermal-epidermal interplay, it has been suggested that an increased diffusion of heparin-binding growth factors such as FGFs, HGF, GM-CSF from dermis to epidermis and vice versa may be favoured by the reported heparanase-induced degradation of heparan sulfate at the basement membrane observed in solar lentigo[@B57]. Alterations in the melanogenic cytokine networks is present also in melasma, an hyperpigmented dysfunction primarily localized on sun-exposed sites, generally the face. Upregulation of genes related to melanogenesis e.g. tyrosinase, TYRP1, TYRP2 and MITF and an increased expression of α-MSH have been detected in lesional epidermis, whereas an over-expression of SCF has been observed in the dermis suggesting, also for this hyperpigmentary disorder, a deregulation of both epidermal and mesenchymal melanogenic cytokine networks leading to melanocyte hyperactivity[@B58][@B59]. In addition, the basement membrane in lesional skin appears distrupted and disorganized, with the presence of the so called pendulous melanocytes. The expression of the metalloproteinase 2 is also increased due to the chronic UV exposure and such up-modulation is possibly responsible for the dysfunction of the basement membrane. These changes may, in turn, excessively activate the dermal-epidermal interactions, further underscoring the crucial role of the signalling network among melanocytes and other skin cell populations in the formation of melasma lesions[@B60][@B61]. An increased number of blood vessels associated with an up-modulation of the vascular endothelial growth factor have been also detected, highlighting the presence of an altered vascularization in melasma lesions[@B62]. Lastly, likewise solar lentigo, accumulation of the melanogenic factor KGF in the lesional epidermis has been observed[@B56]. Very recently, an up-regulation of the secreted frizzled-ralated protein 2 (sFRP2) in the skin of melasma, solar lentigo and acutely UV-irradiated skin has been shown. This over-expression leads to increased melanogenesis through the activation of the β-catenin signalling and thus up-regulation of MITF and tyrosinase in melanocytes. Interestingly, a strong expression of sFRP2 was detected in lesional fibroblasts, further demonstrating the crucial role of the epithelial-mesenchymal interplay in the control of physiological and pathological skin pigmentation[@B63]. One more, an unbalance of fibroblast-derived growth factors able to stimulate melanocyte and induce pigmentation has been observed in other pigmentary disorders: (i) in the benign fibroblastic tumor dermatofibroma, the hyperpigmentation often observed in the above epidermis, has been attributed to the increased secretion of SCF and HGF by the fibroblastic tumour cells[@B64]; (ii) similarly, an heightened release of the same two growth factors by fibroblasts has been suggested to be involved in the epidermal hyperpigmentation of café-au lait macules of neurofibromatosis type 1 (NF1) patients[@B65]; (iii) An increased expression of the fibroblast-derived growth factors SCF, HGF and KGF in the dermis of two patients with a generalized, progressive dyschromatosis disorder[@B66]. Likewise, the hyperpigmentation sometimes observed in both basal cell carcinoma (BCC) and seborrhoeic keratosis (SK) has been linked to an accentuated expression of the keratinocyte-derived ET-1[@B67][@B68] ([Fig. 2](#F2){ref-type="fig"}). Taken together, all these studies show how intricate is the interplay among dermal and epidermal cells with melanocytes and how the variation of one or more of these interactions can result in a variety of different hyperpigmented lesions. On the other hand, changes in the synthesis and release of these messengers has been observed in hypopigmented disorders such as vitiligo. Despite significant studies contributed to a greater knowledge of vitiligo, understanding its pathogenesis is still a challenge. Vitiligo is characterized by the disappearance of functional melanocytes, and multiple mechanisms might contribute to this loss, including genetic defects, metabolic abnormalities, oxidative stress, generation of inflammatory mediators, cell detachment and autoimmune responses. Nevertheless, a growing amount of evidence in recent years argues for intrinsic metabolic defects in melanocytes leading to an intracellular oxidative stress that may act as the initial signal transduction sustaining cell degeneration[@B69]. Such metabolic impairment may be not restricted to melanocytes but also extended to dermal cells[@B70]. According to the idea that an increase of oxidative stress and impaired ability to effectively manage stressful stimuli are some of the hallmarks of vitiligo skin, melanocytes from non lesional areas show alterations of some pathways, including hyperactivation of mitogen-activated protein kinase (MAPK), cyclic AMP response element-binding protein (CREB), and p53 over-expression, leading to a condition of stress induced premature senescence-like phenotype which is characterized by the production of IL-6, matrix metalloproteinase 3, cyclooxygenase 2, and insulin- like growth factor-binding protein 3 (IGFBP3) and IGFBP7[@B71]. Among the alterations reported in vitiligo skin, changes in the production of keratinocyte-derived factors have been described by several authors, showing either an up- or a down-modulation: Kitamura et al.[@B72] described an increased expression of ET-1 and SCF transcripts associated with an higher SCF protein expression in lesional versus non-lesional vitiligo epidermis. The authors reported also a selective deficiency in the expression of SCF receptor c-KIT and MITF at the edge of the lesion, suggesting that the reduced function of the SCF/c-KIT signalling cascade may contribute to melanocyte alterations and loss. On the other hand, other groups demonstrated a reduced production of SCF by keratinocytes of the depigmented epidermis, possibly due to a higher vulnerability of these cells to apoptosis. Consequenlty, this reduced secretion of surviving factors may concur to melanocyte death[@B73][@B74]. In lesional skin, a lower expression of GM-CSF, bFGF and ET-1, associated with a higher amount of the melanocyte inhibitor cytokines IL-6 and tumor necrosis factor-α have been also reported[@B75] evidencing, altogether, the contribution of keratinocyte alterations in the defective homeostasis and loss of vitiligo melanocytes. Recently, an altered pattern of distribution of the adhesion molecule E-cadherin has been described in clinically normal pigmented skin, indicating the presence of melanocyte adhesiveness impairment that, in presence of stress, may facilitate and contribute to melanocyte loss[@B76]. In the dermis, a reduction in the expression of collagen IV and an up-regulation of the ECM protein tenascin have been described, possibly linked to the decreased adhesion of vitiligo melanocytes[@B77][@B78]. As well, an higher expression of the melanocyte inhibitor fibroblast-derived factor DKK1 has been reported in lesional versus non lesional dermis[@B79]. A lower production and release of KGF by lesional fibroblasts, resulting in a reduction of melanosome transfer, has been recently described as an additional factor contributing to vitiligo hypopigmentation[@B80] ([Fig. 3](#F3){ref-type="fig"}). In the treatment of vitiligo, repigmentation frequently begins in the peri-follicular area. This likely arises from the reservoir of melanocyte stem cells (MelSCs) in the hair follicle bulge[@B81]. These quiescent MelSCs reside in the lower portion of the hair follicle as undifferentiated and not characterized by specific markers, but they are defined by their cellular shape and location within the hair follicle, their low proliferative rate and their low levels of KIT and MITF expression[@B82]. Quiescence, maintenance, activation and proliferation of MelSC are mediated by specific activities in the microenvironment that can influence the differentiation and regeneration of melanocytes. In response to wouding or UV irradiation, follicular MelSC migrate towards the basal layer of the epidermis and differentiate into functional epidermis melanocytes. This migration behavior of MelSC following environmental stimuli gives the opportunity to develop therapeutic approaches for treating skin hypopigmentation disorders by manipulating this stem cell population. For istance, narrow-band UV-B exposure has been used to treat patient with vitiligo, thus leading to follicular repigmentation of depigmented skin. The mechanicistic rationale underlying the success of this therapy is related to the proliferation, migration and differentiation of MelSC[@B83].

Nevertheless, during vitiligo treatment some areas are refractory to repigmentation such as hands and feet[@B84]. The most relevant reason seems to be the lower melanocyte density, lower melanocyte stem cells reservoirs and lower baseline levels of epidermal stem cell requiring factors[@B85]. The maturation and function of hair follicle stem cells are regulated by dermal cells, including adipocytes, dermal papilla cells and fibroblasts, and it is plausible that metabolic impairment of dermal cells will affect stem cells. Moreover, the Herlyn group demonstrated that when dermal stem cells are embedded into dermis, a subpopulation migrates to the epidermis and differentiates into melanocytes[@B86].

Melanocyte stem cells have also been identified in the sweat glands of volar skin and they can contribute to the epidermal melanocyte population[@B87]. Furthermore, possible existence of melanocytes or melanoblasts has been observed in human sebaceous glands[@B88].

CONCLUSIONS
===========

Understanding the development and evolution of pigmentary system requires the knowledge of cellular interactions and signaling pathways producing this system. The colour of human skin is determined by the amount and type of melanin pigment produced by melanocytes and transferred to keratinocytes. Nevertheless, the range of phenotypic differences in pigmentary traits it is not only attributed to melanocyte cells but it certainly encompasses other skin cell populations. Changes in these interactions are likely to explain some ethnic differences and, whenever deregulated, the occurrence of pigmentary disorders characterized by either hyper- or hypo-pigmentation.
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![Skin types pigmentation. In lightly pigmented skin, melanosomes are smaller, mainly at early stages I and II of maturation and they are transferred to the surrounding keratinocytes as clusters in membrane bound organelles. In darkly pigmented skin, melanosomes are more abundant, larger, at stage IV and are singly transferred to the neighbouring cells. Their degradation appears also slower than that observed in light skin, as melanins is yet detected in the stratum corneum. Immunohistochemical analysis of the expression of MART-1 in a skin specimen. Nuclei are counterstained with haematoxylin (×200).](ad-28-279-g001){#F1}

![Epithelial-mesenchymal melanogenic interplay and hyperpigmentary disorders: altered expression of growth factors/mediators and their receptors regulating melanocyte functionality has been shown in several hyperpigmentations, including solar/senile lentigo, melasma, dermatofibroma and seborrhoeic keratosis (H&E, ×100). KGF: keratinocyte growth factor, KGFR: keratinocyte growth factor receptor, SCF: stem cell factor, HGF: hepatocyte growth factor, ET-1: endothelin-1, α-MSH: alpha melanocyte-stimulating hormone, ETBR: endothelin B receptor, sFRP2: secreted frizzled-related protein 2, MMP2: metalloproteinase 2, VEGF: vascular endothelial growth factor.](ad-28-279-g002){#F2}

![Vitiligo as a model of deregulated epithelial-mesenchymal melanogenic interplay in hypopigmented disorders (H&E, ×100). KGF: keratinocyte growth factor, SCF: stem cell factor, ET-1: endothelin-1, GM-CSF: granulocyte macrophage colony-stimulating factor, TNF-α: tumor necrosis factor alpha, IL-1α: interleukin 1 alpha, bFGF: basic fibroblast growth factor, DKK1: dickkopf 1.](ad-28-279-g003){#F3}
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